The Zanamivir for Inhalation, cataloged under National Stock Number 6505-01-657-8192, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxosmithkline, Llc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-657-8192 |
| Primary Part Number | NDC00173-0681-22 |
| Item Name | Zanamivir for Inhalation |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxosmithkline, Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC00173-0681-22 PRIMARY | Glaxosmithkline, Llc (USA) |
| Reference | Meaning |
|---|---|
| 1427938 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM163135 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-657-8192 is a Zanamivir for Inhalation, manufactured by Glaxosmithkline, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-657-8192 has 1 manufacturer part number on file: NDC00173-0681-22 (Glaxosmithkline, Llc).
Key specifications for NDC00173-0681-22: Special Features: FOR PANDEMIC STOCKPILE USE ONLY; RELENZA (ZANAMIVIR) INHALATION POWDER W/INHALATION DEVICE; 20 MG ZANAMIVIR PER ROTADISK (EACH BLISTER CONTAINS 5 MG ZANAMIVIR WITH LACTOSE); EACH PACKAGES CONTAINS 5 ROTADISKS; EACH ROTADISKS CONTAINS 4 BLISTERS FOR A TOTAL OF 20 BLISTERS PER PACKAGE; STORE AT 25C (77F); EXCURSIONS PERMITTED TO 15 TO 30C (59 TO 86F) (SEE USP CONTROLLED ROOM TEMPERATURE); Part Name Assigned by Controlling Agency: ZANAMIVIR) W/ INHALATION DEVICE, 5MG/BLISTER, 20 BLISTERS PER PACKAGE. 0 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.